These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30756523)

  • 1. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
    Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
    Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
    Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.
    Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O
    J Pharm Pharm Sci; 2016; 19(3):411-422. PubMed ID: 27806250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.
    Anizan S; Milman G; Desrosiers N; Barnes AJ; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2013 Oct; 405(26):8451-61. PubMed ID: 23954944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
    Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary clearance of 11-nor-9-carboxy-Δ
    Sempio C; Huestis MA; Kaplan B; Klawitter J; Christians U; Henthorn TK
    Drug Test Anal; 2022 Aug; 14(8):1368-1376. PubMed ID: 35332698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.
    Scheidweiler KB; Desrosiers NA; Huestis MA
    Clin Chim Acta; 2012 Nov; 413(23-24):1839-47. PubMed ID: 22771478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.